<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37445426</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>13</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence of Self-Reported Anosmia and Ageusia in Elderly Patients Who Had Been Previously Hospitalized by SARS-CoV-2: The LONG-COVID-EXP Multicenter Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4391</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12134391</ELocationID><Abstract><AbstractText>We explored two different graph methods for visualizing the prevalence of self-reported post-COVID anosmia and ageusia in a large sample of individuals who had been previously hospitalized in five different hospitals. A cohort of 1266 previously hospitalized COVID-19 survivors participated. Participants were assessed at hospitalization (T0) and at three different follow-up periods: 8.4 (T1), 13.2 (T2), and 18.3 (T3) months after hospital discharge. They were asked about the presence of self-reported anosmia and ageusia that they attributed to infection. Anosmia was defined as a self-perceived feeling of complete loss of smell. Ageusia was defined as a self-perceived feeling of complete loss of taste. Data about hospitalization were recorded from medical records. The results revealed that the prevalence of anosmia decreased from 8.29% (<i>n</i> = 105) at hospitalization (T0), to 4.47% (<i>n</i> = 56) at T1, to 3.27% (<i>n</i> = 41) at T2, and 3.35% (<i>n</i> = 42) at T3. Similarly, the prevalence of ageusia was 7.10% (<i>n</i> = 89) at the onset of SARS-CoV-2 infection (T0), but decreased to 3.03% (<i>n</i> = 38) at T1, to 1.99% (<i>n</i> = 25) at T2, and 1.36% (<i>n</i> = 17) at T3. The Sankey plots showed that only 10 (0.8%) and 11 (0.88%) patients exhibited anosmia and ageusia throughout all the follow-ups. The exponential curves revealed a progressive decrease in prevalence, demonstrating that self-reported anosmia and ageusia improved in the years following hospitalization. The female sex (OR4.254, 95% CI 1.184-15.294) and sufferers of asthma (OR7.086, 95% CI 1.359-36.936) were factors associated with the development of anosmia at T2, whereas internal care unit admission was a protective factor (OR0.891, 95% CI 0.819-0.970) for developing anosmia at T2. The use of a graphical method, such as a Sankey plot, shows that post-COVID self-reported anosmia and ageusia exhibit fluctuations during the first years after SARS-CoV-2 infection. Additionally, self-reported anosmia and ageusia also show a decrease in prevalence during the first years after infection, as expressed by exponential bar plots. The female sex was associated with the development of post-COVID anosmia, but not ageusia, in our cohort of elderly patients previously hospitalized due to COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega-Santiago</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3271-5767</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cancela-Cilleruelo</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Jim&#xe9;nez</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuensalida-Novo</LastName><ForeName>Stella</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3832-3644</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Guerrero</LastName><ForeName>Jos&#xe9; D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0001-9378-0285</Identifier><AffiliationInfo><Affiliation>Intelligent Data Analysis Laboratory, Department of Electronic Engineering, ETSE (Engineering School), Universitat de Val&#xe8;ncia (UV), 46100 Burjassot, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Valencian Graduate School and Research Network of Artificial Intelligence (ValgrAI), 46022 Val&#xe8;ncia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellicer-Valero</LastName><ForeName>&#xd3;scar J</ForeName><Initials>&#xd3;J</Initials><Identifier Source="ORCID">0000-0002-0104-1029</Identifier><AffiliationInfo><Affiliation>Image Processing Laboratory (IPL), Universitat de Val&#xe8;ncia, Parc Cient&#xed;fic, 46010 Val&#xe8;ncia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cigar&#xe1;n-M&#xe9;ndez</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Recursos REACT-UE del Programa Operativo de Madrid 2014-2020, en la l&#xed;nea de actuaci&#xf3;n de proyectos de I+D+i en materia de respuesta a COVID 19 (LONG-COVID-EXP-CM)</GrantID><Agency>Fondo Europeo De Desarrollo Regional -</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Sankey plots</Keyword><Keyword MajorTopicYN="N">ageusia</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword><Keyword MajorTopicYN="N">trajectory</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37445426</ArticleId><ArticleId IdType="pmc">PMC10342726</ArticleId><ArticleId IdType="doi">10.3390/jcm12134391</ArticleId><ArticleId IdType="pii">jcm12134391</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rabaan A.A., Smajlovi&#x107; S., Tombuloglu H., &#x106;ordi&#x107; S., Hajdarevi&#x107; A., Kudi&#x107; N., Al Mutai A., Turkistani S.A., Al-Ahmed S.H., Al-Zaki N.A., et al. SARS-CoV-2 infection and multi-organ system damage: A review. Biomol. Biomed. 2023;23:37&#x2013;52. doi: 10.17305/bjbms.2022.7762.</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bjbms.2022.7762</ArticleId><ArticleId IdType="pmc">PMC9901898</ArticleId><ArticleId IdType="pubmed">36124445</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges do Nascimento I.J., O&#x2019;Math&#xfa;na D.P., von Groote T.C., Abdulazeem H.M., Weerasekara I., Marusic A., Puljak L., Civile V.T., Zakarija-Grkovic I., Pericic T.P., et al. International Network of Coronavirus Disease 2019 (InterNetCOVID-19). Coronavirus disease (COVID-19) pandemic: An overview of systematic reviews. BMC Infect. Dis. 2021;21:52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8177249</ArticleId><ArticleId IdType="pubmed">34088271</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocke J., Hopkins C., Philpott C.M., Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta-analysis. Clin. Otolaryngol. 2020;45:914&#x2013;922. doi: 10.1111/coa.13620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13620</ArticleId><ArticleId IdType="pmc">PMC7436734</ArticleId><ArticleId IdType="pubmed">32741085</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf T., Deeks J.J., Dinnes J., Takwoingi Y., Davenport C., Leeflang M.M., Spijker R., Hooft L., Emperador D., Domen J., et al. Cochrane COVID-19 Diagnostic Test Accuracy Group. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst. Rev. 2022;5:CD013665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8407425</ArticleId><ArticleId IdType="pubmed">33620086</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz M., Goyal H., Haghbin H., Lee-Smith W.M., Gajendran M., Perisetti A. The association of &#x201c;loss of smell&#x201d; to COVID-19: A systematic review and meta-analysis. Am. J. Med. Sci. 2021;361:216&#x2013;225. doi: 10.1016/j.amjms.2020.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.09.017</ArticleId><ArticleId IdType="pmc">PMC7604015</ArticleId><ArticleId IdType="pubmed">33349441</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo E.G.M., Andrade R.M., de Abreu de Vasconcellos S.J., Dos Santos P.L., Tanajura D., Quintans-J&#xfa;nior L., Quintans J., Martins-Filho P. Association between chemosensory dysfunctions and inflammatory biomarkers in patients with SARS-CoV-2 infection: A systematic review and meta-analysis. Inflammopharmacology. 2022;30:2079&#x2013;2087. doi: 10.1007/s10787-022-01066-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-01066-z</ArticleId><ArticleId IdType="pmc">PMC9467422</ArticleId><ArticleId IdType="pubmed">36097300</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.D., Ingram J., Sculthorpe N.F. More than 100 persistent symptoms of SARS-CoV-2 (Long COVID): A scoping review. Front. Med. 2021;8:750378. doi: 10.3389/fmed.2021.750378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.750378</ArticleId><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson S.W., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., et al. Global Burden of Disease Long COVID Collaborators Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott M., Driscoll R., Pardhan S. The prevalence of sensory changes in post-COVID syndrome: A systematic review and meta-analysis. Front. Med. 2022;9:980253. doi: 10.3389/fmed.2022.980253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.980253</ArticleId><ArticleId IdType="pmc">PMC9452774</ArticleId><ArticleId IdType="pubmed">36091707</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.-M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson D.L.B., Campbell M., Hopkins C., Smith B., Kelly C., Deary V. Altered smell and taste: Anosmia, parosmia and the impact of long COVID-19. PLoS ONE. 2021;16:e0256998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462678</ArticleId><ArticleId IdType="pubmed">34559820</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Gessa C., Deiana G., Salzano G., Maglitto F., Lechien J.R., Saussez S., Piombino P., Biglio A., Biglioli F., et al. The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients. Life. 2022;12:141. doi: 10.3390/life12020141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020141</ArticleId><ArticleId IdType="pmc">PMC8878431</ArticleId><ArticleId IdType="pubmed">35207429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Journe F., Hans S., Chiesa-Estomba C.M., Mustin V., Beckers E., Vaira L.A., De Riu G., Hopkins C., Saussez S. Severity of anosmia as an early symptom of COVID-19 infection may predict lasting loss of smell. Front. Med. 2020;7:582802. doi: 10.3389/fmed.2020.582802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.582802</ArticleId><ArticleId IdType="pmc">PMC7732577</ArticleId><ArticleId IdType="pubmed">33330539</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.N., Hoang V.T., Dao T.L., Meddeb L., Cortaredona S., Lagier J.-C., Million M., Raoult D., Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Front. Med. 2022;9:794550. doi: 10.3389/fmed.2022.794550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.794550</ArticleId><ArticleId IdType="pmc">PMC8915119</ArticleId><ArticleId IdType="pubmed">35280874</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.K.J., Han R., Zhao J.J., Tan N.K.W., Quah E.S.H., Tan C.J.-W., Chan Y.H., Teo N.W.Y., Charn T.C., See A., et al. Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: Meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Navarro-Pardo E., Cancela-Cilleruelo I., Moro-L&#xf3;pez-Menchero P., Pellicer-Valero O.J. Exploring trajectory curves from loss of smell and taste in previously hospitalized COVID-19 survivors: The LONG-COVID-EXP-CM Multicenter Study. J. Gen. Intern. Med. 2022;37:1821&#x2013;1823. doi: 10.1007/s11606-022-07459-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07459-8</ArticleId><ArticleId IdType="pmc">PMC8863099</ArticleId><ArticleId IdType="pubmed">35194745</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto E., Culakova E., Meng S., Zhang Z., Xu H., Mohile S., Flannery M.A. Overview of Sankey flow diagrams: Focusing on symptom trajectories in older adults with advanced cancer. J. Geriatr. Oncol. 2022;13:742&#x2013;746. doi: 10.1016/j.jgo.2021.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgo.2021.12.017</ArticleId><ArticleId IdType="pmc">PMC9232856</ArticleId><ArticleId IdType="pubmed">35000890</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Torres-Macho J., Guijarro C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero O.J., Plaza-Manzano G. Trajectory of gastrointestinal symptoms in previously hospitalized COVID-19 survivors: The Long COVID Experience Multicenter Study. Viruses. 2023;15:1134. doi: 10.3390/v15051134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15051134</ArticleId><ArticleId IdType="pmc">PMC10221203</ArticleId><ArticleId IdType="pubmed">37243220</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung T.W.-H., Sridhar S., Zhang A.J., Chan K.-H., Li H.-L., Wong F.K.-C., Ng M.-Y., Tsang R.K.-Y., Lee A.C.-Y., Fan Z., et al. Olfactory dysfunction in coronavirus disease 2019 patients: Observational cohort study and systematic review. Open Forum Infect. Dis. 2020;7:ofaa199. doi: 10.1093/ofid/ofaa199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa199</ArticleId><ArticleId IdType="pmc">PMC7284010</ArticleId><ArticleId IdType="pubmed">32548209</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan N., Lv Z.-H., Sun C.-R., Wen Y.-Y., Tao T.-Y., Qian D., Tao F.-P., Yu J.-H. Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Front. Public Health. 2023;11:1112383. doi: 10.3389/fpubh.2023.1112383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1112383</ArticleId><ArticleId IdType="pmc">PMC9978404</ArticleId><ArticleId IdType="pubmed">36875356</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Are patients exhibiting post-Coronavirus Disease (COVID) symptoms at 12 months the same at 5 or 9 months? The fluctuating nature of post-COVID. Clin. Infect. Dis. 2022;75:e1208. doi: 10.1093/cid/ciac007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac007</ArticleId><ArticleId IdType="pmc">PMC9383161</ArticleId><ArticleId IdType="pubmed">34989807</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Florencio L.L., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Palacios-Ce&#xf1;a D., Raveendran A.V. Proposed integrative model for post-COVID symptoms. Diabetes Metab. Syndr. 2021;15:102159. doi: 10.1016/j.dsx.2021.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.032</ArticleId><ArticleId IdType="pmc">PMC8168334</ArticleId><ArticleId IdType="pubmed">34186367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.K., Sayad R., Mahmoud I.A., El-Monem A.M.A., Badry S.H., Ibrahim I.H. &#x201c;Anosmia&#x201d; the mysterious collateral damage of COVID-19. J. Neurovirol. 2022;28:189&#x2013;200. doi: 10.1007/s13365-022-01060-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-022-01060-9</ArticleId><ArticleId IdType="pmc">PMC8898086</ArticleId><ArticleId IdType="pubmed">35249186</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L. Olfactory dysfunction in COVID-19: Pathology and long-term implications for brain health. Trends Mol. Med. 2022;28:781&#x2013;794. doi: 10.1016/j.molmed.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9212891</ArticleId><ArticleId IdType="pubmed">35810128</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Hans S., Saussez S. Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19. J. Intern. Med. 2021;290:464&#x2013;465. doi: 10.1111/joim.13257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13257</ArticleId><ArticleId IdType="pmc">PMC8014317</ArticleId><ArticleId IdType="pubmed">33527593</ArticleId></ArticleIdList></Reference><Reference><Citation>Locatello L.G., Oreste G. Long-term recovery from COVID-19 anosmia: Promising findings and unanswered questions. J. Intern. Med. 2021;290:462&#x2013;463. doi: 10.1111/joim.13247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13247</ArticleId><ArticleId IdType="pmc">PMC8014859</ArticleId><ArticleId IdType="pubmed">33462906</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Intern. Med. 2023;23:e230750. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirican E., Bal T. COVID-19 disease severity to predict persistent symptoms: A systematic review and meta-analysis. Prim. Health Care Res. Dev. 2022;23:e69. doi: 10.1017/S1463423622000585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1463423622000585</ArticleId><ArticleId IdType="pmc">PMC9706304</ArticleId><ArticleId IdType="pubmed">36352492</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Byrne L., Webster K.E., MacKeith S., Philpott C., Hopkins C., Burton M.J. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst. Rev. 2022;9:CD013876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9443431</ArticleId><ArticleId IdType="pubmed">36062970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>